======= MITF =======
== Gene Information ==
* **Official Symbol**: MITF
* **Official Name**: melanocyte inducing transcription factor
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4286|4286]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O75030|O75030]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=MITF&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MITF|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/156845|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene is a transcription factor that contains both basic helix-loop-helix and leucine zipper structural features. The encoded protein regulates melanocyte development and is responsible for pigment cell-specific transcription of the melanogenesis enzyme genes. Heterozygous mutations in the this gene cause auditory-pigmentary syndromes, such as Waardenburg syndrome type 2 and Tietz syndrome. [provided by RefSeq, Aug 2017].
* **UniProt Summary**: N/A
|DUF3371|
|HLH|
|canonical Wnt signaling pathway involved in negative regulation of apoptotic process|
|melanocyte differentiation|
|positive regulation of DNA-templated transcription, initiation|
|pigment cell differentiation|
|regulation of DNA-templated transcription, initiation|
|developmental pigmentation|
|osteoclast differentiation|
|bone remodeling|
|E-box binding|
|regulation of osteoclast differentiation|
|canonical Wnt signaling pathway|
|pigmentation|
|tissue remodeling|
|myeloid leukocyte differentiation|
|regulation of myeloid leukocyte differentiation|
|protein dimerization activity|
|myeloid cell differentiation|
|regulation of myeloid cell differentiation|
|DNA-binding transcription repressor activity, RNA polymerase II-specific|
|cell fate commitment|
|negative regulation of cell migration|
|regulation of leukocyte differentiation|
|negative regulation of cell motility|
|negative regulation of cellular component movement|
|camera-type eye development|
|negative regulation of locomotion|
|leukocyte differentiation|
|Wnt signaling pathway|
|cell-cell signaling by wnt|
|eye development|
|visual system development|
|sensory system development|
|chromatin binding|
|cell surface receptor signaling pathway involved in cell-cell signaling|
|DNA-binding transcription activator activity, RNA polymerase II-specific|
|regulation of hemopoiesis|
|RNA polymerase II proximal promoter sequence-specific DNA binding|
|sensory organ development|
|hemopoiesis|
|protein-containing complex|
|hematopoietic or lymphoid organ development|
|transcription, DNA-templated|
|nucleic acid-templated transcription|
|immune system development|
|RNA biosynthetic process|
|regulation of cell migration|
|negative regulation of transcription by RNA polymerase II|
|negative regulation of apoptotic process|
|negative regulation of programmed cell death|
|regulation of cell motility|
|regulation of locomotion|
|negative regulation of cell death|
|regulation of cellular component movement|
|nucleobase-containing compound biosynthetic process|
|cell-cell signaling|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|negative regulation of transcription, DNA-templated|
|positive regulation of transcription by RNA polymerase II|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|organic cyclic compound biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|positive regulation of transcription, DNA-templated|
|regulation of apoptotic process|
|negative regulation of biosynthetic process|
|protein-containing complex assembly|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|regulation of programmed cell death|
|regulation of cell population proliferation|
|cellular nitrogen compound biosynthetic process|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|regulation of immune system process|
|RNA metabolic process|
|regulation of cell death|
|cellular macromolecule biosynthetic process|
|negative regulation of gene expression|
|positive regulation of RNA metabolic process|
|macromolecule biosynthetic process|
|regulation of cell differentiation|
|protein-containing complex subunit organization|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp531|THZ1 0.06μM R08 exp531]]|-2.05|
|[[:results:exp247|UM0130462 0.025 to 0.035μM day4 R05 exp247]]|-1.91|
|[[:results:exp389|PF-06409577 20μM R07 exp389]]|-1.83|
|[[:results:exp435|JQ1 0.8μM R08 exp435]]|-1.72|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 9/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|5/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 15502
* **Expression level (log2 read counts)**: 0.47
{{:chemogenomics:nalm6 dist.png?nolink |}}